DK2661276T3 - Topisk sammensætning omfattende botulinumtoksin og et farvestof - Google Patents
Topisk sammensætning omfattende botulinumtoksin og et farvestof Download PDFInfo
- Publication number
- DK2661276T3 DK2661276T3 DK11855190.2T DK11855190T DK2661276T3 DK 2661276 T3 DK2661276 T3 DK 2661276T3 DK 11855190 T DK11855190 T DK 11855190T DK 2661276 T3 DK2661276 T3 DK 2661276T3
- Authority
- DK
- Denmark
- Prior art keywords
- composition
- toxin
- botulinum toxin
- dye
- topical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
Claims (12)
1. Topisk eller transdermal sammensætning, der omfatter et botulinumtoksin og et farvestof.
2. Sammensætning ifølge krav 1, hvor sammensætningen omfatter en bærer, hvor bæreren omfatter et positivt ladet polypeptidskelet, hvortil der er fastgjort én eller flere virkning s gmpper udvalgt fra gruppen bestående af (gly)p-RGRDDRRQRRR-(gly)q, (gly)p-YGRKKRRQRRR-(gly)q og (gly)p-RKKRRQRRR(gly)q, hvor p og q med sænket skrift hvert uafhængigt er et heltal fra 0 til 20.
3. Sammensætning ifølge krav 2, hvor bæreren omfatter aminosyresekvensen RKKRRQRRR-G-(K)is-G-RKKRRQRRR.
4. Sammensætning ifølge krav 1, hvor botulinumtoksinet er udvalgt fra gruppen bestående af botulinumtoksin serotype A, B, Cl, D, E, F og G.
5. Sammensætning ifølge krav 4, hvor botulinumtoksinet er et oprenset botulinumtoksinmolekyle.
6. Sammensætning ifølge krav 1, hvor farvestoffet er et synligt farvestof.
7. Sammensætning ifølge krav 6, hvor det synlige farvestof er et kunstigt farvestof.
8. Sammensætning ifølge krav 6, hvor farvestoffet er udvalgt fra gruppen bestående af FD&C Blue No. 1, FD&C Blue No. 2, FD&C Green No. 3, FD&C Red No. 40, FD&C Red No. 3, FD&C Yellow No. 5 og FD&C Red No. 6.
9. Sammensætning ifølge krav 6, hvor det synlige farvestof er et naturligt fødevarefarvestof.
10. Sammensætning ifølge krav 9, hvor det naturlige fødevarefarvestof er udvalgt fra gruppen bestående af karamelfarvestof, annatto, karmin, betanin, gurkemeje, safran, paprika, pandan og clitoria ternatea.
11. Sammensætning ifølge krav 1, hvor farvestoffet er et fluorescerende farvestof.
12. Sammensætning ifølge krav 11, hvor det fluorescerende farvestof er udvalgt fra gruppen bestående af fluorescein-natrium, rhodamin B, Acridin Orange, grønt fluorescerende protein, kurkumin, og zinksulfid.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161430868P | 2011-01-07 | 2011-01-07 | |
PCT/US2011/066728 WO2012094163A1 (en) | 2011-01-07 | 2011-12-22 | Methods and kits for topical application, removal, and inactivation of therapeutic or cosmetic toxin compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2661276T3 true DK2661276T3 (da) | 2017-10-02 |
Family
ID=46457668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK11855190.2T DK2661276T3 (da) | 2011-01-07 | 2011-12-22 | Topisk sammensætning omfattende botulinumtoksin og et farvestof |
Country Status (17)
Country | Link |
---|---|
US (3) | US20120294844A1 (da) |
EP (2) | EP2661276B1 (da) |
JP (4) | JP6444032B2 (da) |
BR (1) | BR112013017311A2 (da) |
CY (1) | CY1119427T1 (da) |
DK (1) | DK2661276T3 (da) |
ES (1) | ES2641068T3 (da) |
HK (1) | HK1247553A1 (da) |
HR (1) | HRP20171483T1 (da) |
HU (1) | HUE035057T2 (da) |
LT (1) | LT2661276T (da) |
NO (1) | NO2661276T3 (da) |
PL (1) | PL2661276T3 (da) |
PT (1) | PT2661276T (da) |
RS (1) | RS56460B1 (da) |
SI (1) | SI2661276T1 (da) |
WO (1) | WO2012094163A1 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008531732A (ja) * | 2005-03-03 | 2008-08-14 | ルバンス セラピュティックス インク. | ボツリヌス毒素の局所塗布及び経皮送達のための組成物及び方法 |
PL2379104T3 (pl) | 2008-12-31 | 2018-07-31 | Revance Therapeutics, Inc. | Preparaty toksyny botulinowej do wstrzykiwania |
BRPI1015938A2 (pt) * | 2009-06-25 | 2016-09-27 | Revance Therapeutics Inc | formulações da toxina botulínica livre de albumina |
WO2013142755A1 (en) * | 2012-03-22 | 2013-09-26 | Revance Therapeutics, Inc. | Method of treatment of wrinkles using topical chemodenervating agents |
CN109069608A (zh) * | 2015-10-29 | 2018-12-21 | 雷文斯治疗公司 | 具有长的治疗或美容效应持续时间的可注射肉毒杆菌毒素制剂以及其使用方法 |
ES2755815T3 (es) | 2016-09-13 | 2020-04-23 | Allergan Inc | Composiciones de toxina de Clostridium no proteicas estabilizadas |
EP3624819A4 (en) * | 2017-05-18 | 2021-03-24 | Revance Therapeutics, Inc. | METHOD OF TREATMENT OF CERVICAL DYSTONIA |
US20210162026A1 (en) | 2017-08-28 | 2021-06-03 | Revance Therapeutics, Inc. | Transmucosal botulinum toxin compositions, kits, and methods for treating bladder disorders |
US20210321696A1 (en) * | 2020-04-20 | 2021-10-21 | First Step Holdings, Llc | Covid mask |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4286016A (en) * | 1979-04-12 | 1981-08-25 | The Drackett Company | Pouch bleach |
US4797128A (en) | 1984-12-10 | 1989-01-10 | Quadrex Hps, Inc. | Method of and apparatus for cleaning garments and soft goods contaminated with nuclear, chemical and/or biological contaminants |
US5877278A (en) | 1992-09-24 | 1999-03-02 | Chiron Corporation | Synthesis of N-substituted oligomers |
US5624636A (en) | 1994-11-07 | 1997-04-29 | Univ. Of Texas Board Of Regents | Hypochlorite based disinfectant for dental impressions |
US6444209B1 (en) | 1996-10-28 | 2002-09-03 | Wisconsin Alumni Research Foundation | Hybrid botulinal neurotoxins |
US6566574B1 (en) | 1998-06-30 | 2003-05-20 | Sandia Corporation | Formulations for neutralization of chemical and biological toxants |
US6417423B1 (en) * | 1998-09-15 | 2002-07-09 | Nanoscale Materials, Inc. | Reactive nanoparticles as destructive adsorbents for biological and chemical contamination |
GB2386246B (en) | 2001-11-01 | 2005-06-29 | Marconi Applied Techn Ltd | Electron beam tube apparatus |
US6706092B2 (en) * | 2002-04-17 | 2004-03-16 | Alliedsignal Inc. | Chemical/Biological decontamination filter |
US7582596B1 (en) | 2002-11-06 | 2009-09-01 | Taylor Lawnie H | Products, methods and equipment for removing stains from fabrics using an alkali metal hydroxide/hypochlorite salt mixture |
US8048423B2 (en) * | 2003-12-09 | 2011-11-01 | Allergan, Inc. | Botulinum toxin therapy for skin disorders |
US7776292B2 (en) * | 2004-01-16 | 2010-08-17 | Cdic, Inc. | Method and apparatus for bioweapon decontamination |
LT2985039T (lt) | 2004-03-03 | 2018-11-12 | Revance Therapeutics, Inc. | Botulino toksinų vietinis taikymas ir jų įvedimas per odą |
WO2005114186A1 (ja) * | 2004-05-20 | 2005-12-01 | Wako Pure Chemical Industries, Ltd. | ヒアルロン酸バインディングプロテインを用いたヒアルロン酸の測定方法 |
US20080220021A1 (en) | 2005-02-14 | 2008-09-11 | Pankaj Modi | Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis |
JP2008531732A (ja) * | 2005-03-03 | 2008-08-14 | ルバンス セラピュティックス インク. | ボツリヌス毒素の局所塗布及び経皮送達のための組成物及び方法 |
US20070154493A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin needing botulinum toxin type a treatment |
EP3141248A1 (en) * | 2006-03-24 | 2017-03-15 | Auxilium International Holdings, Inc. | Stabilized compositions containing alkaline labile drugs |
EP2007435B1 (en) * | 2006-03-31 | 2019-12-18 | Massachusetts Institute Of Technology | System for targeted delivery of therapeutic agents |
DE102006019447A1 (de) * | 2006-04-24 | 2007-10-25 | Dressler, Dirk, Dr. | Markierung von Botulinum Toxin |
ES2441961T3 (es) * | 2007-02-15 | 2014-02-07 | Allergan, Inc. | Composiciones de toxina botulínica y métodos |
CA2678580C (en) * | 2007-03-06 | 2012-07-17 | Steris Inc. | Transportable decontamination unit and decontamination process |
JP2009001423A (ja) * | 2007-05-21 | 2009-01-08 | Life:Kk | 感染性廃棄物用回収袋又は容器および感染性廃棄物処理方法 |
US8445650B2 (en) * | 2007-09-25 | 2013-05-21 | Thomas Jefferson University | Mutant botulinum neurotoxin serotype A polypeptide and uses thereof |
US20090148342A1 (en) * | 2007-10-29 | 2009-06-11 | Bromberg Steven E | Hypochlorite Technology |
US20090250626A1 (en) * | 2008-04-04 | 2009-10-08 | Hexatech, Inc. | Liquid sanitization device |
PL2379104T3 (pl) * | 2008-12-31 | 2018-07-31 | Revance Therapeutics, Inc. | Preparaty toksyny botulinowej do wstrzykiwania |
BRPI1015938A2 (pt) | 2009-06-25 | 2016-09-27 | Revance Therapeutics Inc | formulações da toxina botulínica livre de albumina |
-
2011
- 2011-12-22 US US13/334,283 patent/US20120294844A1/en not_active Abandoned
- 2011-12-22 US US13/978,673 patent/US20140154237A1/en not_active Abandoned
- 2011-12-22 JP JP2013548424A patent/JP6444032B2/ja not_active Expired - Fee Related
- 2011-12-22 SI SI201131290T patent/SI2661276T1/sl unknown
- 2011-12-22 PL PL11855190T patent/PL2661276T3/pl unknown
- 2011-12-22 DK DK11855190.2T patent/DK2661276T3/da active
- 2011-12-22 WO PCT/US2011/066728 patent/WO2012094163A1/en active Application Filing
- 2011-12-22 HU HUE11855190A patent/HUE035057T2/en unknown
- 2011-12-22 EP EP11855190.2A patent/EP2661276B1/en not_active Revoked
- 2011-12-22 NO NO11855190A patent/NO2661276T3/no unknown
- 2011-12-22 EP EP17178151.1A patent/EP3248614A1/en active Pending
- 2011-12-22 RS RS20171000A patent/RS56460B1/sr unknown
- 2011-12-22 PT PT118551902T patent/PT2661276T/pt unknown
- 2011-12-22 LT LTEP11855190.2T patent/LT2661276T/lt unknown
- 2011-12-22 BR BR112013017311A patent/BR112013017311A2/pt not_active Application Discontinuation
- 2011-12-22 ES ES11855190.2T patent/ES2641068T3/es active Active
-
2016
- 2016-09-09 JP JP2016177053A patent/JP6605420B2/ja not_active Expired - Fee Related
-
2017
- 2017-09-13 CY CY20171100970T patent/CY1119427T1/el unknown
- 2017-10-04 HR HRP20171483TT patent/HRP20171483T1/hr unknown
-
2018
- 2018-05-25 HK HK18106889.1A patent/HK1247553A1/zh unknown
- 2018-07-05 JP JP2018128169A patent/JP2018188447A/ja active Pending
-
2020
- 2020-07-02 JP JP2020114910A patent/JP2020172519A/ja active Pending
- 2020-12-07 US US17/114,486 patent/US20210189326A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2020172519A (ja) | 2020-10-22 |
LT2661276T (lt) | 2017-12-11 |
EP3248614A1 (en) | 2017-11-29 |
NO2661276T3 (da) | 2017-12-30 |
RS56460B1 (sr) | 2018-01-31 |
EP2661276B1 (en) | 2017-08-02 |
CY1119427T1 (el) | 2018-03-07 |
JP2017025083A (ja) | 2017-02-02 |
JP6444032B2 (ja) | 2018-12-26 |
PL2661276T3 (pl) | 2018-03-30 |
JP2018188447A (ja) | 2018-11-29 |
BR112013017311A2 (pt) | 2016-10-04 |
HK1247553A1 (zh) | 2018-09-28 |
US20140154237A1 (en) | 2014-06-05 |
ES2641068T3 (es) | 2017-11-07 |
PT2661276T (pt) | 2017-10-06 |
EP2661276A1 (en) | 2013-11-13 |
SI2661276T1 (sl) | 2017-12-29 |
HUE035057T2 (en) | 2018-05-02 |
US20210189326A1 (en) | 2021-06-24 |
HRP20171483T1 (hr) | 2017-12-01 |
JP6605420B2 (ja) | 2019-11-13 |
JP2014502969A (ja) | 2014-02-06 |
US20120294844A1 (en) | 2012-11-22 |
WO2012094163A1 (en) | 2012-07-12 |
EP2661276A4 (en) | 2014-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2661276T3 (da) | Topisk sammensætning omfattende botulinumtoksin og et farvestof | |
JP6559849B2 (ja) | 注射用ボツリヌス毒素製剤 | |
EP2656859B1 (en) | Topical application and transdermal delivery of botulinum toxins | |
EP1856139B1 (en) | Compositions and methods for topical application and transdermal delivery of an oligopeptide | |
ES2654342T3 (es) | Tratamiento antienvejecimiento para la piel | |
US9180081B2 (en) | Compositions and methods for topical application and transdermal delivery of botulinum toxins | |
CA2559454A1 (en) | Substances with a probiotic action used in deodorants | |
US9211248B2 (en) | Compositions and methods for topical application and transdermal delivery of botulinum toxins |